undefined

Rachel Haurwitz

President and CEO of Caribou Biosciences, a pioneer in CRISPR-based genome editing and off-the-shelf CAR T therapies. She co-founded the company and has been recognized for her contributions to the field.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app